130 related articles for article (PubMed ID: 33338546)
1. Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study.
Musale V; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YH
Peptides; 2021 Feb; 136():170472. PubMed ID: 33338546
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action of the antidiabetic peptide [S4K]CPF-AM1 in db/db mice.
Musale V; Moffett RC; Owolabi B; Conlon JM; Flatt PR; Abdel-Wahab YHA
J Mol Endocrinol; 2021 Feb; 66(2):115-128. PubMed ID: 33252358
[TBL] [Abstract][Full Text] [Related]
3. Actions of PGLa-AM1 and its [A14K] and [A20K] analogues and their therapeutic potential as anti-diabetic agents.
Owolabi BO; Musale V; Ojo OO; Moffett RC; McGahon MK; Curtis TM; Conlon JM; Flatt PR; Abdel-Wahab YHA
Biochimie; 2017 Jul; 138():1-12. PubMed ID: 28392407
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic actions of esculentin-2CHa(1-30) and its stable analogues in a diet-induced model of obesity-diabetes.
Vasu S; Ojo OO; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YHA
Amino Acids; 2017 Oct; 49(10):1705-1717. PubMed ID: 28836148
[TBL] [Abstract][Full Text] [Related]
5. Glucoregulatory, endocrine and morphological effects of [P5K]hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance.
Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):769-81. PubMed ID: 27068334
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms mediating the beneficial metabolic effects of [Arg4]tigerinin-1R in mice with diet-induced obesity and insulin resistance.
Ojo OO; Srinivasan DK; Owolabi BO; McGahon MK; Moffett RC; Curtis TM; Conlon JM; Flatt PR; Abdel-Wahab YH
Biol Chem; 2016 Aug; 397(8):753-64. PubMed ID: 26966929
[TBL] [Abstract][Full Text] [Related]
7. Amphibian host-defense peptides with potential for Type 2 diabetes therapy - an updated review.
Conlon JM; Owolabi BO; Flatt PR; Abdel-Wahab YHA
Peptides; 2024 May; 175():171180. PubMed ID: 38401671
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: potent activity against oral pathogens.
McLean DT; McCrudden MT; Linden GJ; Irwin CR; Conlon JM; Lundy FT
Regul Pept; 2014 Nov; 194-195():63-8. PubMed ID: 25447193
[TBL] [Abstract][Full Text] [Related]
9. Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance.
Ojo OO; Srinivasan DK; Owolabi BO; Vasu S; Conlon JM; Flatt PR; Abdel-Wahab YH
PLoS One; 2015; 10(10):e0141549. PubMed ID: 26512980
[TBL] [Abstract][Full Text] [Related]
10. The frog skin host-defense peptide CPF-SE1 improves glucose tolerance, insulin sensitivity and islet function and decreases plasma lipids in high-fat fed mice.
Srinivasan D; Ojo OO; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YHA
Eur J Pharmacol; 2015 Oct; 764():38-47. PubMed ID: 26123844
[TBL] [Abstract][Full Text] [Related]
11. [I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice.
Srinivasan DK; Ojo OO; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YH
Acta Diabetol; 2016 Apr; 53(2):303-15. PubMed ID: 26138324
[TBL] [Abstract][Full Text] [Related]
12. A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice.
Perry RA; Craig SL; Gault VA; Flatt PR; Irwin N
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34370015
[TBL] [Abstract][Full Text] [Related]
13. Frog skin peptides (tigerinin-1R, magainin-AM1, -AM2, CPF-AM1, and PGla-AM1) stimulate secretion of glucagon-like peptide 1 (GLP-1) by GLUTag cells.
Ojo OO; Conlon JM; Flatt PR; Abdel-Wahab YH
Biochem Biophys Res Commun; 2013 Feb; 431(1):14-8. PubMed ID: 23291176
[TBL] [Abstract][Full Text] [Related]
14. Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice.
Mohan S; McCloskey AG; McKillop AM; Flatt PR; Irwin N; Moffett RC
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129811. PubMed ID: 33309687
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.
Patterson S; de Kort M; Irwin N; Moffett RC; Dokter WH; Bos ES; Miltenburg AM; Flatt PR
Diabetes Obes Metab; 2015 Aug; 17(8):760-70. PubMed ID: 25929155
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes.
Ojo OO; Srinivasan DK; Owolabi BO; Flatt PR; Abdel-Wahab YH
Biochimie; 2015 Feb; 109():18-26. PubMed ID: 25483926
[TBL] [Abstract][Full Text] [Related]
17. A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice.
Craig SL; Perry RA; Vyavahare SS; Ng MT; Gault VA; Flatt PR; Irwin N
Biochem Pharmacol; 2020 Jan; 171():113723. PubMed ID: 31756326
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure-activity study.
Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
Amino Acids; 2016 Feb; 48(2):535-47. PubMed ID: 26439377
[TBL] [Abstract][Full Text] [Related]
19. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes.
Moffett RC; Patterson S; Irwin N; Flatt PR
Diabetes Metab Res Rev; 2015 Mar; 31(3):248-55. PubMed ID: 25256010
[TBL] [Abstract][Full Text] [Related]
20. Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice.
Pathak NM; Millar PJB; Pathak V; Flatt PR; Gault VA
Mol Cell Endocrinol; 2018 Jan; 460():200-208. PubMed ID: 28754350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
